

Save money on Insulin Degludec (Tresiba) in 2026 with coupons, savings cards, patient assistance programs, and the $35 insulin cap.
Insulin Degludec (Tresiba) is one of the most effective basal insulins available, but it's also one of the most expensive. Without insurance, Tresiba can cost $300 to $500 per box of FlexTouch pens. Even with insurance, copays can be steep if Tresiba is on a non-preferred tier.
The good news: there are multiple programs, laws, and savings tools that can dramatically reduce — or even eliminate — your out-of-pocket cost for Insulin Degludec. Here's everything you need to know in 2026.
The Inflation Reduction Act (IRA) caps the cost of insulin at $35 per month for Medicare Part D enrollees. This applies to all covered insulins, including Insulin Degludec (Tresiba). If you have Medicare Part D, you should never pay more than $35/month for your Tresiba prescription.
Many commercial insurers have voluntarily adopted similar $35 caps. Check with your insurance plan to see if this applies to you. If your pharmacy is charging more, ask your pharmacist to verify your plan's insulin cost-sharing rules.
Novo Nordisk offers a Tresiba Savings Card for commercially insured patients. Eligible patients may pay as little as $0 to $25 per month for their Insulin Degludec prescription. Key details:
For patients who pay cash (no insurance), Novo Nordisk's Insulin Value Program caps the cost at $35 for up to a 90-day supply of Insulin Degludec. This is a manufacturer program, not tied to insurance. You can enroll at NovoCare.com or by calling 1-888-668-6444.
If you're uninsured or underinsured and meet income requirements, Novo Nordisk's Patient Assistance Program can provide Insulin Degludec for free. Eligibility typically requires:
Apply through NovoCare.com or call 1-888-668-6444. Your doctor's office can also submit the application on your behalf.
If you don't qualify for manufacturer programs or need additional savings, prescription discount cards can help reduce costs at retail pharmacies:
Important: Discount cards cannot be combined with insurance. They're most useful for cash-paying patients or when your insurance copay is higher than the discount card price.
Insulin Degludec may be on different formulary tiers depending on your insurance plan. If it's on a non-preferred or specialty tier, your copay will be higher. Options:
If you have a high-deductible health plan (HDHP), you may pay full price until you hit your deductible. The Tresiba Savings Card or Insulin Value Program can help bridge this gap early in the year.
Several states have enacted their own insulin cost caps, often $25 to $100 per month regardless of insurance type. These laws vary by state and may cover Insulin Degludec. Check your state's health department or insurance commissioner website for details.
States with insulin cost caps include (but are not limited to): Colorado, Illinois, Maine, Minnesota, New Mexico, New York, Washington, and West Virginia. More states continue to pass similar legislation.
If you need help finding programs you qualify for, these free databases can help:
If cost remains a barrier even after exploring all programs, talk to your doctor about alternatives. Insulin Glargine biosimilars (Semglee, Basaglar) are available at significantly lower prices and are effective for most patients. See our guide: Alternatives to Insulin Degludec.
If you're struggling to find Insulin Degludec at any price, use MedFinder to locate pharmacies with stock near you. See: How to Find Insulin Degludec in Stock Near You.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.